David Hodson
Robert Turner Professor of Diabetic Medicine and Director (interim) of The Bukhman Centre for Research Excellence in Type 1 Diabetes · www.rdm.ox.ac.uk · University of Oxford
Quick answer: David Hodson is Robert Turner Professor of Diabetic Medicine and Director (interim) of The Bukhman Centre for Research Excellence in Type 1 Diabetes at University of Oxford. David Hodson shows an active PhD hiring signal as of 2026-09-11.
⭐ 2026 Hodson Group: Understanding how glucagon-like peptide-1 (GLP1) and gastric inhibitory polypeptide (GIP) receptors contribute to metabolism in complex tissues.
Research interests
Cellular metabolism, glucagon-like peptide-1 (GLP1) and gastric inhibitory polypeptide (GIP) receptors, regulation of glucose homeostasis, food intake and inflammation, drug targets for the treatment of diabetes and obesity, cellular heterogeneity in pancreatic islet, hormone secretion, regenerative medicine approaches
Selected publications (since 2023)
[2025] Tong JCL. et al, Cell Metab, 37, 1698 - 1714.e5. Localized GLP1 receptor pre-internalization directs pancreatic alpha cell to beta cell communication.
[2024] Cuozzo F. et al, Cell Rep, 43. LDHB contributes to the regulation of lactate levels and basal insulin secretion in human pancreatic β cells.
[2023] Ast J. et al, Nat Commun, 14. Revealing the tissue-level complexity of endogenous glucagon-like peptide-1 receptor expression and signaling.
[2026] Murakami T. et al, J Diabetes Investig. Adaptive islet biology and comprehensive incretin physiology: Emerging perspectives from Asia and Europe.
[2026] Hovmøller MS. et al, New Phytol. Long-term surveillance reveals hybridization by nuclear reassortment and intercontinental spread as major evolutionary drivers in wheat yellow rust.
[202
Frequently asked questions
Is David Hodson hiring PhD students at University of Oxford?
Yes. As of 2026-09-11, David Hodson's faculty page shows a PhD hiring signal: 2026 Hodson Group: Understanding how glucagon-like peptide-1 (GLP1) and gastric inhibitory polypeptide (GIP) receptors contribute to metabolism in complex tissues..
What does David Hodson research?
Cellular metabolism, glucagon-like peptide-1 (GLP1) and gastric inhibitory polypeptide (GIP) receptors, regulation of glucose homeostasis, food intake and inflammation, drug targets for the treatment of diabetes and obesity, cellular heterogeneity in pancreatic islet, hormone secretion, regenerative
Data last updated: 2026-09-11 · Source: phd-match.com faculty database.
Is David Hodson a match for your research?
Upload your CV and get matched to professors who fit — with hiring signals.
Start matching